Pages

▼
Showing posts with label SSRIs. Show all posts
Showing posts with label SSRIs. Show all posts
Tuesday, November 27, 2012

What If the Institute of Medicine Wrote a Report and Nobody Followed it? - the Case of the Standards for Developing Trustworthy Guidelines

›
For over 20 years, clinical practice guidelines (CPGs) have been touted to improve health care quality and control costs.  Enormous numbers ...
2 comments:
Tuesday, February 21, 2012

BLOGSCAN - Television Advertising Revenue and the Anechoic Effect

›
We have often discussed the anechoic effect , how cases involving or discussions of the topics we address on Health Care Renewal , the conce...
2 comments:
Wednesday, February 17, 2010

Quintiles to More Heavily Directly Invest in the Drugs Which it Evaluates - But Not to Worry, Says an Expert?

›
The Associated Press just reported on the latest trend in commercially sponsored clinical research, direct investment by contract research o...
3 comments:
Tuesday, September 08, 2009

The Lexapro Marketing Plan Was Meant to Promote Marketing (Surprise?)

›
Last week, Gardiner Harris writing for the NY Times noted that the US Senate Special Committee on Aging had made public part of Forest Labo...
2 comments:
Wednesday, August 19, 2009

High Costs and Poor Outcomes - A Lesson About the Suppression of Research

›
Last week, blogger Alison Bass was one of the few to comment on a new article on the risks of antidepressant medications published electron...
3 comments:
Monday, March 23, 2009

JAMA Editors Try Attacking the Messenger

›
Early this month, yet another story surfaced about allegations of undisclosed conflicts of interest affecting the author of a highly publici...
5 comments:
Sunday, October 26, 2008

BLOGSCAN - Annals of Stealth Marketing

›
On the Reidbord's Reflections blog , Dr Steven Reidbord recounted how he was invited to speak at a big and glitzy event, part of the nat...
Tuesday, October 07, 2008

Thoughts on Charles Nemeroff's Not So Excellent Adventure

›
The saga of Dr Charles Nemeroff was most recently discussed on Health Care Renewal here . We had first posted about his failure to disclose ...
7 comments:
Sunday, September 28, 2008

BLOGSCAN - Duplicate Publication about an SSRI

›
On the Clinical Psychology and Psychiatry Blog, the anonymous blogger described an interesting example of apparent dual publication on a se...
Thursday, July 24, 2008

Attacking "Side Effects" with Logical Fallacies, Version 2

›
Side Effects by Alison Bass continues to generate controversy. As described by a reviewer in the New England Journal of Medicine,(1) the bo...
1 comment:
Friday, July 18, 2008

Attacking "Side Effects" with Logical Fallacies

›
Concerns about manipulation and suppression of the clinical research literature are gaining more traction. Recently, Alison Bass published S...
6 comments:
Thursday, May 08, 2008

SSRIs, Stealth Marketing, and Public Radio

›
We have previously posted about instances of stealth marketing in public television ( here and here .) Now Shannon Brownlee and Jeanne Lenz...
6 comments: